OBJECTIVES: As adipose tissue is usually obtained during local or general anesthesia in clinical studies, these two forms of anesthesia were presently compared as regards lipolysis induced by catecholamines in isolated human fat cells. DESIGN: Fat samples from the abdominal subcutaneous region were obtained ®rst during local anesthesia (lidocaine) given so that the anesthetic agent did not in¯uence lipolysis and second, during gastric banding under general anesthesia (propofol) immediately after skin incision. SUBJECTS: Eleven obese patients, drug free and otherwise healthy. MEASUREMENTS: Isolated fat cells were incubated in the presence or absence of increasing concentrations of different lipolysis agents, acting at adrenoceptor or various post-receptor levels in the lipolytic cascade. Glycerol release to the incubation medium was measured as an index of lipolysis. RESULTS: All agonists caused a concentration dependent increase (terbutaline, dobutamine, CGP 12177, forskolin, dibutyryl cyclic AMP, isoprenaline and noradrenaline) or inhibition (clonidine) of glycerol release. The comparison of data from local and general anesthesia procedures showed no statistical difference in glycerol response for any of the drugs used. CONCLUSIONS: Adrenergic regulation of lipolysis is not in¯uenced by the mode of sampling, at least not in subcutaneous fat cells of obese subjects obtained during local anesthesia with lidocaine as compared to general anesthesia with propofol.
Introduction
Obesity is a major risk factor for the development of chronic disorders, such as hypertension, non-insulindependent diabetes, dyslipidemia and atherosclerosis, which in turn may cause ischemic heart disease, stroke and premature death. 1±3 Alterations in free fatty acid metabolism may play an important role in the development of metabolic and cardiovascular complications to obesity as reviewed. 3±7 Since adipocyte lipolysis is a major regular of the circulating free fatty acid level, it is of interest to study this metabolic event in obesity and related disorders.
The knowledge of adipose tissue metabolism in man can be only partly extrapolated from ®ndings in adipose tissue of other species. Therefore different procedures have been developed in order to remove human fat portions for metabolic studies in vitro. These procedures also include the use of general or local anesthesia. Several methods have been published, which allow removal of tissue specimens during local anesthesia without getting any in¯uence of the local anesthetic agent on lipolysis. 8, 9 When adipose tissue is obtained during surgery, there might be any alteration in adipose metabolism since lipolysis is continuously activated after induction of general anesthesia. 10 Whether or not the latter involves an impairment of adipocyte functions is unknown since no studies have been published regarding the in¯u-ence of general anesthesia on lipolysis regulation in a particular individual. Previously, separate groups of subjects were always compared, either local or general anesthesia. 9, 11 Catecholamines are the major lipolysis stimulating hormones in man. The action of these hormones on lipolysis is altered in a number of clinical conditions as reviewed. 12 In the present study, we have compared the adrenergic regulation of lipolysis in fat cells obtained from the same subject before (namely local anesthesia) and during general anesthesia. We used ®eld block local anesthesia with lidocaine, 8 since it was known not to alter fat cells lipolysis 8 and general anesthesia with propofol, since the latter agent has been used for a long time in the routine general anesthesia at the hospital. Propofol is highly lipophilic and there is obviously a possibility that it would be accumulated in adipocytes and involve an impairment of adipocyte functions.
Subjects and methods

Subjects
The study included ®ve obese men and six obese women (body mass index ranged from 39.1±53.4 kg/ m 2 ) who underwent gastric banding involving a laparotomy because of obesity. All were drug free and otherwise healthy. The clinical data are given in Table  1 . The subjects were informed in detail about the investigation and their consent was obtained. The study was approved by the hospital's committee on Ethics.
Biopsy procedure under local anesthesia
The ®rst biopsy was obtained between one and two weeks before surgery and was performed at our laboratory at 8 am. After the subjects had rested in the supine position for 15 min, blood pressure was recorded with a digital blood pressure device. Venous blood samples were obtained for the determination of glucose, lipids, catecholamines and insulin. They were all analysed by the hospital's routine chemistry laboratory except for insulin which was measured with a radioimmunoassay kit (Pharmacia, Uppsala, Sweden). A subcutaneous fat biopsy (about 2 g) was obtained under ®eld block local anesthesia with 10± 15 ml of 0.5% lidocaine from the abdominal region immediately to the right or the left of the umbilicus, as described previously. 8 It has been shown that this form of local anesthesia does not in¯uence lipolysis in vitro'. 8 
Surgery procedure
Patients were fasted from 10 pm until the start of the surgery procedures. General anesthesia was induced at 8 am by propofol in a fat emulsion (Diprivan R , Zeneca, Bristol, UK) in combination with fentanyl and midazolan, and maintained by propofol and a mixture of oxygen and air. Muscle relaxation was induced by suxamethonium and maintained by abracurium. Intravenous saline was administered prior to sampling the fat biopsy. The intra-operative sample of abdominal subcutaneous fat was taken at the beginning of the surgical procedure, within minutes after the skin incision, and 20±30 min after the induction of general anesthesia.
Isolation of fat cells and determination of fat cell size and number
The tissue was immediately transported to the laboratory in saline at 37 C and isolated fat cells were prepared from the fat by collagenase treatment, as described by Rodbell. 13 Brie¯y, small fragments of approximately 5±10 mg were incubated for 60 min in a shaking bath with 0.5 g/l collagenase in 5 ml of Krebs±Ringer phosphate buffer (10 mmol/l, pH 7.4) supplemented with 40 g/l dialysed bovine serum albumin at 37 C, thus isolating the fat cells from the stroma cells. Fat cells were then ®ltered twice, washed three times through a silk cloth with a 10 g/l albumin and collagenase-free buffer. Then they were resuspended in the appropriate buffer for lipolysis. Fat cell size was estimated by direct microscopy and the mean adipocyte diameter and standard deviation were calculated from the diameter of 100 cells.
14 Because of the spherical shape and high lipid content of the cells (95%), the mean adipocyte weight can be calculated from the mean adipocyte diameter and cell volume and the surface area can be calculated from the mean diameter. This procedure has been described previously. 15 Total lipid content in the incubate was measured gravimetrically after an organic extraction with heptane. The adipocytes number in each incubate was calculated by dividing the total lipid weight by the mean adipocyte weight.
Lipolysis experiments
Isolated fat cells were incubated as described in detail earlier. 16 In brief, a diluted isolated cell suspension (about 5±10 000 cells per ml) was incubated in duplicate for two hours in the presence or absence of increasing concentrations of different lipolysis agents acting on different levels of the lipolytic cascade: the natural catecholamine noradrenaline acting on all adrenoceptors subtypes, the agonist isoprenaline acting on all three b-adrenoceptor subtypes, the respective selective b1-and b2-adrenoceptor agonists terbutaline and dobutamine, the partial selective b3-adrenoceptor agonist CGP 12177, and the antilipolytic a2-adrenoceptor agonist clonidine. Furthermore forskolin was used to stimulate adenylate cyclase, as well as dibutyryl cyclic AMP (dcAMP) which is a phosphodiesterase resistant cyclic AMP analogue that activates the cyclic AMP-dependent protein kinase. All incubations were performed at 37 C in Krebs±Ringer phosphate buffer (pH 7.4) and supplemented with glucose (1 g/l), bovine serum albumin (20 g/l), with air as the gas phase. The pharmalogical agents were added simultaneously at the start of the incubation. The concentration range used for each drug was dependent on its lipolytic performance. The overall range was from 10 72 to 10 73 mol/l. As discussed in detail previously, 17 adenosine leaking out from isolated fat cells may interfere with the a2-adrenoceptor-mediated antilipolytic effect of catecholamine on basal lipolysis rate. Even if there is a minimal in¯uence of adenosine contamination in our dilute incubation system, adenosine deaminase (1 mU/ ml) was added in the a2-adrenoceptor experiments. In that way antilipolytic interactions with traces of adenosine that might still be present and induce additional inhibitory effects was prevented. But the in¯uence of adenosine on lipolysis was negligible when adipocytes were stimulated with other lipolytic drugs. Therefore we preferred not to add adenosine deaminase in the remaining concentration-response experiments.
Glycerol release from the 2 h incubation medium was determined using an automated bioluminescence assay 18 and was used as a measurement of the lipolysis rate since this metabolite is not reutilised by human fat cells to any signi®cant extend. All agonists caused a dose dependent increase or inhibition of glycerol release that reached a plateau at the highest agonist concentrations. The sensitivity to agonist action was de®ned as the pD2 value, namely the negative logarithm of the ED50 value. The latter was de®ned as the agonist concentration giving half maximum effect. These ED50 values (expressed as log mol/l) were determined by linear regression analysis after log-logit transformation of the ascending (b-agonists) or descending (a2-agonist) part of the individual concentration-response curves. The pD2 value re¯ects speci®c agonist-receptor interactions, since at this ED50 value, a selective agonist has few, if any, interactions with other adrenoceptor subtypes. 19 Lipolysis rates in the presence or absence of maximum effective agonist concentrations were related to the number of incubated cells and expressed per cell number. The maximum effect on lipolysis indicate agonist responsiveness.
Drugs and chemicals
Bovine serum albumin (fraction V), ATP, Clostridium histolyticum collagenase type I, adenosine deaminase, forskolin, dibutyryl cyclic AMP, glycerol kinase from E. Coli and clonidine were obtained from Sigma (St Louis, MO, U.S.A.). Noradrenaline and (±) isoprenaline hydrochloride came from Ha Èssle (Mo Èlndal, Sweden), terbutaline sulfate from Draco (Lund, Sweden), dobutamine hydrochloride from Lilly (Indianapolis, IN, USA), CGP 12177 from Ciba Geigy (Basel, Switzerland). ATP monitoring reagent containing ®rely luciferase came from LKB Wallac (Turku, Finland).
Statistical analysis
Values were given as the mean AE standard error of the mean (s.e.m.). Statistical analysis was determined using Student paired t-test or two-way analysis of variance (ANOVA). A power analysis was also performed to test if the sample size was large enough to detect a variation between both forms of anesthesia, that differed signi®cantly from zero.
Results
Clinical data are shown in Table 1 . Patients tended to be upper-body obese since the mean waist-hip ratio was more than 1.00. As expected for such obese people, fasting plasma levels of insulin, glucose and triglycerides were increased. Figure 1 shows mean concentration response curves for three selective b-adrenoceptor agonists in subcu- 
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V Large et al taneous fat cells obtained under general and local anesthesia. These curves are expressed as rates of lipolysis since both sensitivity and responsiveness (maximum effect) were investigated. The glycerol release for each agonist was stimulated in a concentration dependent fashion. The results were essentially the same at all agonist concentration tested when both anesthesia procedures were compared (Figure 1 ). The responsiveness and sensitivity (Table 2) for terbutaline, dobutamine and CGP 12177 were not in¯uenced by the mode of sampling of the subcutaneous fat tissue. Moreover no statistical difference between both forms of anesthesia was calculated as regards the sensitivity for other lipolytically active agents such as noradrenaline and isoprenaline (Table 2) . Table 3 shows the responsiveness of forskolin, dcAMP, clonidine, isoprenaline and noradrenaline. As expected the maximum effects of these agents were considerably increased compared to basal lipolysis in both groups, with the highest difference for isoprenaline. There was no statistical difference regarding the maximum effect for each agonist between local and general anesthesia.
Power analysis was performed in order to test if the sample size was large enough to detect small variations in lipolysis between both forms of anesthesia. The difference for each parameter (pD2 and/or responsiveness) as regards local vs general anesthesia was calculated for each drug. The power to detect or mean difference that was statistically different from zero at P`0.05 for each of these parameters in the whole group, was always higher than 0.97.
Discussion
This investigation has compared lipolysis in subcutaneous fat cells obtained from the same patient under local or general anesthesia.
It appears that the response to selective adrenoceptor agonists (b1, b2, b3 and a2) is almost identical whatever the mode of anesthetic procedure used (namely local or general). The same is true for the response to the natural hormone (noradrenaline) and the non-selective agonist isoprenaline. Moreover, the post adrenoceptor response appears not to be in¯u-enced by the anesthetic procedures since the response to forskolin and dcAMP is the same in both forms of anesthesia.
When`negative' data are shown (namely lack of difference), it is always possible that minor variations were missed due to a small sample size causing so called type I statistical errors. However the results of power analysis indicated that the sample was large enough even to detect small effects of anesthesia on lipolysis. The probability of that a type I error occurred in any of the statistical test was less than 3%.
This study was performed on subcutaneous adipose tissue from obese subjects who were investigated under a common form of general anesthesia with propofol. Thus, we do not know how the data will relate to non-obese subjects, to other adipose regions or to other forms of general anesthesia.
In summary, this study shows that catecholamine action on lipolysis`in vitro' is very similar in sub- Table 3 Basal and maximum lipolysis rates in fat cells obtained under local and general anesthesia. Glycerol release (mmola10 7 cellsa2 h) is shown in the absence (basal) or presence of maximum effective concentrations of the adenylate cyclase activator forskolin, the cAMP analogue dcAMP, the selective a2-adrenoceptor agonist clonidine, the non-selective b-adrenoceptor agonist isoprenaline and the natural hormone noradrenaline (NA). The differences of values (mean AE s.e.m. between both forms of anesthesia were statistically compared using Student paired t-test.
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General anesthesia P Lipolysis in human fat cells V Large et al cutaneous fat cells obtained from obese subjects under standardized procedures of local and general anesthesia. Since basal-and catecholamine-stimulated-lipolysis is the same in fat cells obtained by sampling fat under general or local anesthesia, it appears that it might be possible to pool data generated from these two forms of anesthesia, at least when subcutaneous adipose tissue is obtained from obese subjects using the present type of general anesthesia.
